GB2587755A - A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin - Google Patents
A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin Download PDFInfo
- Publication number
- GB2587755A GB2587755A GB2100486.6A GB202100486A GB2587755A GB 2587755 A GB2587755 A GB 2587755A GB 202100486 A GB202100486 A GB 202100486A GB 2587755 A GB2587755 A GB 2587755A
- Authority
- GB
- United Kingdom
- Prior art keywords
- user
- practitioner
- variable
- prescribed
- electromagnetophoretic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract 26
- 239000002537 cosmetic Substances 0.000 title claims abstract 13
- 230000001225 therapeutic effect Effects 0.000 title claims abstract 13
- 230000002452 interceptive effect Effects 0.000 claims abstract 4
- 239000004615 ingredient Substances 0.000 claims abstract 3
- 238000002716 delivery method Methods 0.000 claims 5
- 238000004590 computer program Methods 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 230000007613 environmental effect Effects 0.000 claims 3
- 239000000470 constituent Substances 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Primary Health Care (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Electrotherapy Devices (AREA)
- Medicinal Preparation (AREA)
Abstract
A method and apparatus for the user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin care ingredients of a quality, or at a rate, depth, intensity, dosage or concentration, selected or specified by the user or practitioner, effected by an interactive user or practitioner programmable electromagnetophoretic delivery device receiving at least one variable user-defined or practitioner-prescribed outcome selected or specified by the user or practitioner.
Claims (27)
1. A method for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin care ingredients, comprising; a) inputting at least one variable, user-defined or practitioner-prescribed outcome selected or specified by the user or practitioner into a system adapted for programming an interactive user or practitioner programmable electromagnetophoretic delivery device; b) optionally, receiving one or more additional variable parameters regarding the user- controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery method; c) executing an algorithm to derive at least one control instruction for the electromagnetophoretic delivery device utilising the at least one variable user- defined or practitioner-prescribed outcome, and where received, the one or more variable additional parameters; and d) providing the at least one control instruction to the electromagnetophoretic delivery device to effect the user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin care ingredients of a quality, or at a rate, depth, dosage, intensity or concentration, selected or specified by the user or practitioner.
2. The method of claim 1 wherein the one or more additional variable parameters is a variable user, patient or subject parameter.
3. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable environmental parameter.
4. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable therapeutic, cosmetic or skin care composition parameter.
5. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable environmental parameter that is at least one of an ambient temperature value, an ambient atmospheric pressure value, and an ambient humidity value.
6. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable therapeutic, cosmetic or skin care composition parameter that is a characteristic of the therapeutic, cosmetic or skin care composition or of the substance or active constituent of the therapeutic, cosmetic or skin care composition to be delivered by the electromagnetophoretic delivery device.
7. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable user, patient or subject parameter that is a characteristic of the dermal layer to which the electromagnetophoretic delivery device is to be applied.
8. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable environmental parameter that is a geographical location of the user, patient or subject.
9. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable user, patient or subject parameter that is an ethnicity of the user, patient or subject.
10. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a variable user, patient or subject parameter that is an age group of the user, patient or subject.
11. The method of any one of the preceding claims, wherein the one or more additional variable parameters is a therapeutic, cosmetic or skin care composition parameter that is the identity of the therapeutic, cosmetic or skin care composition to be delivered by the electromagnetophoretic delivery device.
12. The method of any one of the preceding claims, wherein the at least one variable user- defined or practitioner-prescribed outcome is the choice of a specific quality of a multifunctional therapeutic, cosmetic or skin care composition to be delivered by the electromagnetophoretic delivery device.
13. The method of any one of the preceding claims, wherein the at least one variable user- defined or practitioner-prescribed outcome is the desired rate, depth, level of intensity, dosage or concentration, of delivery of the therapeutic, cosmetic or skin care composition to be delivered by the electromagnetophoretic delivery device.
14. The method of any one of the preceding claims, wherein the at least one control instruction is provided utilising a wireless communication device.
15. An interactive user or practitioner programmable electromagnetophoretic delivery device, adapted to perform the method of any one of the preceding claims.
16. The interactive user or practitioner programmable electromagnetophoretic delivery device of claim 15, comprising; a) an interface adapted to receive at least one variable user-defined or practitioner- prescribed outcome selected or specified by the user or practitioner; b) a data input module adapted to optionally receive one or more additional variable parameters regarding the user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery method; c) a processor adapted to execute an algorithm to derive at least one control instruction for the electromag netophoretic delivery device by processing the at least one variable user-defined or practitioner-prescribed outcome, and where received, the one or more variable additional parameters; and d) a delivery module adapted to utilise the at least one control instruction to effect the user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery method.
17. A system for programming the electromagnetophoretic delivery device of claim 15 or claim 16, comprising; a) an interface adapted to receive at least one variable user-defined or practitioner- prescribed outcome selected or specified by the user or practitioner; b) a data input module adapted to optionally receive one or more additional variable parameters regarding the user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery method; c) a processor adapted to execute an algorithm to derive at least one control instruction for the electromagnetophoretic delivery device by processing the at least one variable user-defined or practitioner-prescribed outcome, and where received, the one or more variable additional parameters; and d) an output module adapted to provide the at least one instruction to the electromagnetophoretic delivery device to effect the user-controlled or practitioner- prescribed transdermal, intradermal or transappendageal delivery method.
18. A computer program including at least one command, which, when executed on a computing system, is adapted to perform the method steps of any one of claims 1 to 14.
19. A computer readable medium incorporating a computer program in accordance with Claim 18
20. A data signal encoding at least one command and being adapted to be receivable by at least one computing system, wherein, when the encoded command is executed on the computing system, the computing system performs the method steps of at least one of Claims 1 to 14.
21. Use of the device of claim 15 or claim 16 to perform the method steps of at least one of Claims 1 to 14.
22. Use of the system of claim 17 to perform the method steps of at least one of Claims 1 to 14.
23. Use of the computer program of claim 18 to perform the method steps of at least one of Claims 1 to 14.
24. Use of the computer readable medium of claim 19 to perform the method steps of at least one of Claims 1 to 14.
25. Use of the data signal of claim 20 to perform the method steps of at least one of Claims 1 to 14.
26. A therapeutic, cosmetic or skin care composition for use in the method of at least one of claims 1 to 14.
27. A kit comprising the device of claim 15 or claim 16 and the composition of claim 26 for use in the method of at least one of claims 1 to 14.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018902547A AU2018902547A0 (en) | 2018-07-13 | A Method and Apparatus for User-Controlled Transdermal, Intradermal or Transappendageal Delivery of Cosmetic or Skin Care Ingredients | |
| AU2019901932A AU2019901932A0 (en) | 2019-06-04 | A Method and Apparatus for User-Controlled or Practitioner-Prescribed Transdermal, Intradermal or Transappendageal Delivery of Therapeutic, Cosmetic or Skin Care Ingredients | |
| PCT/AU2019/050715 WO2020010388A1 (en) | 2018-07-13 | 2019-07-09 | A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin care ingredients |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB202100486D0 GB202100486D0 (en) | 2021-03-03 |
| GB2587755A true GB2587755A (en) | 2021-04-07 |
| GB2587755A8 GB2587755A8 (en) | 2021-05-19 |
Family
ID=69142206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2100486.6A Withdrawn GB2587755A (en) | 2018-07-13 | 2019-07-09 | A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2019301569A1 (en) |
| GB (1) | GB2587755A (en) |
| WO (1) | WO2020010388A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12499774B2 (en) | 2021-05-19 | 2025-12-16 | Tencent America LLC | Method and apparatus for UAV and UAV controller group membership update |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5869326A (en) * | 1996-09-09 | 1999-02-09 | Genetronics, Inc. | Electroporation employing user-configured pulsing scheme |
| US6009346A (en) * | 1998-01-02 | 1999-12-28 | Electromagnetic Bracing Systems, Inc. | Automated transdermal drug delivery system |
| US6029090A (en) * | 1997-01-27 | 2000-02-22 | Herbst; Ewa | Multi-functional electrical stimulation system |
| WO2007079189A2 (en) * | 2005-12-30 | 2007-07-12 | Tti Ellebeau, Inc. | System and method for remote based control of an iontophoresis device |
| US20120191052A1 (en) * | 2000-10-06 | 2012-07-26 | Ip Holdings, Inc. | Intelligent activated skin patch system |
| WO2013033782A1 (en) * | 2011-09-09 | 2013-03-14 | International Scientific Pty Ltd | Method and device for transdermal delivery of substances |
| WO2014075136A1 (en) * | 2012-11-14 | 2014-05-22 | International Scientific Pty Ltd | A device, system, method, computer program and data signal for the control of a transdermal delivery device |
| US20160220804A1 (en) * | 2015-02-03 | 2016-08-04 | L'oreal | Apparatus and method for skin treatment using continuous light |
-
2019
- 2019-07-09 AU AU2019301569A patent/AU2019301569A1/en not_active Abandoned
- 2019-07-09 WO PCT/AU2019/050715 patent/WO2020010388A1/en not_active Ceased
- 2019-07-09 GB GB2100486.6A patent/GB2587755A/en not_active Withdrawn
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5869326A (en) * | 1996-09-09 | 1999-02-09 | Genetronics, Inc. | Electroporation employing user-configured pulsing scheme |
| US6029090A (en) * | 1997-01-27 | 2000-02-22 | Herbst; Ewa | Multi-functional electrical stimulation system |
| US6009346A (en) * | 1998-01-02 | 1999-12-28 | Electromagnetic Bracing Systems, Inc. | Automated transdermal drug delivery system |
| US20120191052A1 (en) * | 2000-10-06 | 2012-07-26 | Ip Holdings, Inc. | Intelligent activated skin patch system |
| WO2007079189A2 (en) * | 2005-12-30 | 2007-07-12 | Tti Ellebeau, Inc. | System and method for remote based control of an iontophoresis device |
| WO2013033782A1 (en) * | 2011-09-09 | 2013-03-14 | International Scientific Pty Ltd | Method and device for transdermal delivery of substances |
| WO2014075136A1 (en) * | 2012-11-14 | 2014-05-22 | International Scientific Pty Ltd | A device, system, method, computer program and data signal for the control of a transdermal delivery device |
| US20160220804A1 (en) * | 2015-02-03 | 2016-08-04 | L'oreal | Apparatus and method for skin treatment using continuous light |
Also Published As
| Publication number | Publication date |
|---|---|
| GB202100486D0 (en) | 2021-03-03 |
| AU2019301569A1 (en) | 2021-02-04 |
| WO2020010388A1 (en) | 2020-01-16 |
| GB2587755A8 (en) | 2021-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4606298A3 (en) | Strategic treatment of pressure ulcer using sub-epidermal moisture values | |
| CN111564192B (en) | Control method of neck massager, neck massager and server | |
| GB2598503A8 (en) | Control of an electronic vaporizer | |
| US20190038965A1 (en) | Method and Apparatus for Adjusting Game Scene | |
| WO2021092178A3 (en) | Medical fluid delivery system including analytics for managing patient engagement and treatment compliance | |
| CN104799837B (en) | Blood pressure blood flow control method, system, massage apparatus and intelligent mobile terminal | |
| WO2008153689A4 (en) | Expert system for insulin pump therapy | |
| US20190018444A1 (en) | Wearable apparatus and method for controlling vr apparatus | |
| US10905222B2 (en) | Personalization skin care product system, method and computer program product | |
| WO2020116917A3 (en) | Device, system, and method for providing treatment information for skin beauty treatment | |
| CN110579978B (en) | Method and device for adjusting household appliance and storage medium | |
| GB2587755A (en) | A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin | |
| AU2013344818A1 (en) | A device, system, method, computer program and data signal for the control of a transdermal delivery device | |
| CN109685741A (en) | A kind of image processing method, device and computer storage medium | |
| Tsuchiya et al. | Continuous flash suppression | |
| US20130258818A1 (en) | Information processing apparatus, information processing method, and program | |
| US9283138B1 (en) | Communication techniques and devices for massage therapy | |
| CN119302837B (en) | Control method and device for hand massage device, terminal equipment and storage medium | |
| CN112785490B (en) | Image processing methods, devices and electronic equipment | |
| CN105426167A (en) | Wound treatment APP (application) system based on big data processing | |
| Erdogan et al. | Previous nail surgery is a risk factor for recurrence of ingrown nails | |
| HK1158885A2 (en) | A method and system of controlling playing of internet multi-media playing device using intelligent mobile terminal | |
| CN113384393B (en) | Control method and device of massage equipment, storage medium and massage equipment | |
| US20240138545A1 (en) | Cosmetic use of a device emitting millimeter wave rf radiation | |
| KR102884311B1 (en) | Smart beauty device and device controlling the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |